Por: RTTNews Health January 05, 2024
Theravance Biopharma, Inc. () announced results from the Phase 4 PIFR-2 study of YUPELRI inhalation solution, the nebulized long-acting muscarinic antagonist approved in the U.S. for maintenance treatment of Chronic Obstructive Pulmonary Disease or COPD. The study did not show a statistically significant difference between YUPELRI and Spiriva HandiHaler on the primary endpoint, change from baseline in trough forced expiratory volume in one... + full article
Newsweek USA Nation January 18, 2024
The private information and medical records of America's 18 million veterans has been put at risk by the temporary removal of one element of the cybersecurity program at the U.S. Department of Veterans Affairs, according to current and former officials and contractors.If... + más
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
RTTNews USA Health December 28, 2023
CytoSorbents () issued an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board analysis for the U.S. and Canadian STAR-T randomized controlled trial. STAR-T is a multi-center trial that... + más
68 confirmed dead after plane crashes in central Nepal | CBS News
Nepal begins national day of mourning after deadly plane crash kills at least 68 | ABC7
RTTNews USA Health September 14, 2023
First Wave BioPharma, Inc., () announced an agreement with Sanofi () to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop for gastrointestinal indications. First Wave will receive from Sanofi an exclusive, global license... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Tuesday, March 28 | Orlando Sentinel
Bleacher Report USA Sports June 08, 2023
Is Dalvin Cook hinting on social media that he will sign in Miami?Hours after ESPN's reported that the Minnesota Vikings plan to release their star running back, Cook posted a photo of himself celebrating in Miami. The Dolphins are one of the teams signing Cook, per... + más
Jets’ will ‘turn the stones over’ on running back Dalvin Cook, Robert Saleh says | Fox News
Dalvin Cook Officially Released After Vikings Failed to Find Trade Partner for RB | Bleacher Report
Slate USA Politics April 13, 2023
For decades, the pharmaceutical and biotech industry tried to avoid the politics of abortion. On Friday, that strategy came to a crashing halt. U.S. District Judge Matthew Kacsmaryk’s ordering the Food and Drug Administration to revoke approval of mifepristone, the first drug... + más
What Are the Duties of A Trustee? | Forbes
Shaikin: Baseball embracing the 'flukes' and plenty of added revenue this postseason | Los Angeles Times
Ars Technica USA Science April 11, 2023
Navigate Filter by topic Settings Front page layout Site theme - Apr 10, 2023 10:34 pm UTC / Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic, which provides legal medication abortion services,... + más
Why birth control could actually make your dating life suck | New York Post
Council Post: 16 Bad Habits Tech Leaders Wish Developers Would Drop | Forbes
9to5Mac USA Tech October 03, 2022
After launching in 2019, to help organizations manage their Apple fleet, Kandji went to work on solving additional problems. Today, announced its new Device Harmony platform, which is aimed at bridging the gap between and InfoSec teams, so they can truly work together to keep... + más
Logitech finally makes a wireless mechanical keyboard with a true Mac layout | Ars Technica
What are all the solutions needed to run a fleet of Macs at Work? | 9to5Mac
About iurex | Privacy Policy | Disclaimer |